ArticleDigestive diseases and sciences2018

Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.

Yara Nasser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.